ATOSSA THERAPEUTICS, INC. Defined Contribution Plan, Cost
ATOSSA THERAPEUTICS, INC. (ATOS) reported Defined Contribution Plan, Cost of $50.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-08-07
- ATOSSA THERAPEUTICS, INC. defined contribution plan, cost for the quarter ending 2026-06-30 was $50.00K, a 20.63% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. defined contribution plan, cost for the quarter ending 2026-03-31 was $53.00K, a 29.33% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. defined contribution plan, cost for the quarter ending 2025-12-31 was $214.00K, a 45.58% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. defined contribution plan, cost for the quarter ending 2025-09-30 was $48.00K, a 23.08% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. defined contribution plan, cost for fiscal 2025 was $400.00K, a 33.33% increase from fiscal 2024.
- ATOSSA THERAPEUTICS, INC. defined contribution plan, cost for fiscal 2024 was $300.00K, a 0.00% change from fiscal 2023.
- ATOSSA THERAPEUTICS, INC. defined contribution plan, cost for fiscal 2023 was $300.00K, a 50.00% increase from fiscal 2022.
- ATOSSA THERAPEUTICS, INC. defined contribution plan, cost for fiscal 2022 was $200.00K.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 6 month | Defined Contribution Plan, Cost 9 month | Defined Contribution Plan, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $50.00K 10-Q · filed 2026-08-07 | $103.00K 10-Q · filed 2026-08-07 | $317.00K derived: sum of 3 quarters · filed 2026-08-07 | $365.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $53.00K 10-Q · filed 2026-05-08 | $267.00K derived: sum of 2 quarters · filed 2026-05-08 | $315.00K derived: sum of 3 quarters · filed 2026-05-08 | $378.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $214.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $262.00K derived: sum of 2 quarters · filed 2026-03-25 | $325.00K derived: sum of 3 quarters · filed 2026-08-07 | $400.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $48.00K 10-Q · filed 2025-11-12 | $111.00K derived: sum of 2 quarters · filed 2026-08-07 | $186.00K 10-Q · filed 2025-11-12 | $333.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $63.00K 10-Q · filed 2026-08-07 | $138.00K 10-Q · filed 2026-08-07 | $285.00K derived: sum of 3 quarters · filed 2026-08-07 | $324.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $75.00K 10-Q · filed 2026-05-08 | $222.00K derived: sum of 2 quarters · filed 2026-05-08 | $261.00K derived: sum of 3 quarters · filed 2026-05-08 | $298.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $147.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $186.00K derived: sum of 2 quarters · filed 2026-03-25 | $223.00K derived: sum of 3 quarters · filed 2026-03-25 | $300.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $39.00K 10-Q · filed 2025-11-12 | $76.00K derived: sum of 2 quarters · filed 2025-11-12 | $153.00K 10-Q · filed 2025-11-12 | $316.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $37.00K 10-Q · filed 2025-08-12 | $114.00K 10-Q · filed 2025-08-12 | $277.00K derived: sum of 3 quarters · filed 2025-08-12 | $308.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $77.00K 10-Q · filed 2025-05-13 | $240.00K derived: sum of 2 quarters · filed 2025-05-13 | $271.00K derived: sum of 3 quarters · filed 2025-05-13 | $321.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $163.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $194.00K derived: sum of 2 quarters · filed 2025-03-25 | $244.00K derived: sum of 3 quarters · filed 2025-03-25 | $300.00K 10-K · filed 2025-03-25 |
| 2023-09-30 | $31.00K 10-Q · filed 2024-11-12 | $81.00K derived: sum of 2 quarters · filed 2024-11-12 | $137.00K 10-Q · filed 2024-11-12 | $235.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $50.00K 10-Q · filed 2024-08-12 | $106.00K 10-Q · filed 2024-08-12 | $204.00K derived: sum of 3 quarters · filed 2024-08-12 | $238.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $56.00K 10-Q · filed 2024-05-13 | $154.00K derived: sum of 2 quarters · filed 2024-05-13 | $188.00K derived: sum of 3 quarters · filed 2024-05-13 | $224.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $132.00K derived: sum of 2 quarters · filed 2024-04-01 | $168.00K derived: sum of 3 quarters · filed 2024-04-01 | $200.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $34.00K 10-Q · filed 2023-11-13 | $70.00K derived: sum of 2 quarters · filed 2023-11-13 | $102.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $36.00K 10-Q · filed 2023-08-14 | $68.00K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $34.00K 10-Q · filed 2023-05-15 | |||
| 2021-09-30 | $12.00K 10-Q · filed 2022-11-07 | $25.00K derived: sum of 2 quarters · filed 2022-11-07 | $58.00K 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $13.00K 10-Q · filed 2022-08-08 | $46.00K 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | $33.00K 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |